期刊文献+

阿霉素磁性壳聚糖微球的制备及释放实验 被引量:2

Preparation and Release Exam of Magnetic Chitosan Nano-spheres of Doxorubicin
原文传递
导出
摘要 应用改进的悬浮交联技术制备磁性壳聚糖(chitosan,CS)纳米微球。结果显示:该药物微球基本呈球形,其粒径在200-800 nm之间,并且显示了好的磁响应性。阿霉素(doxorubicin,DOX)为试验药物,DOX和CS以化学键(-N=C-)结合在一起,药物含量在1%-15%(w/w)。pH值的大小对其药物体外释放试验的影响很大,当pH为1、2和4时,7 d内药物的释放从22.0%、13.4%降至4.1%。该微球为pH敏感的磁靶向药物微球。 Magnetic chitosan(CS) nano-spheres were prepared by the modified suspension cross-linking technique.The results demonstrated that the magnetic drug nano-spheres are mainly spherical in form with a size of 200 to 800 nm,and show good magnetic responsivity.Here,Doxorubicin was used as exam drug.Glutaraldehyde connects Doxorubicin to CS by the chemical bond(-N=C-), and the drug content is in range of 1% to 15%(w/w).The chemical bond is broken depending on pH,so pH is the important factor for the release of doxorubicin.The doxorubicin release was 22.0%,13.4%,and 4.1% in the space of 7d,when pH was 1,2,4.So the nano-spheres are pH-sensitive magnetic targeting drug micro-spheres.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2010年第1期86-90,共5页 Journal of Biomedical Engineering
基金 广东省自然科学基金资助项目(04006966) 广东省卫生科研基金资助项目(A2003697)
关键词 纳米粒子 乳液 磁性药物靶向 药物载体 Nano-particle Emulsion Magnetic drug targeting Drug carrier
  • 相关文献

参考文献7

  • 1韩涛,李富荣,周汉新.阿霉素纳米微球靶向药物制剂的研究进展[J].中国药物与临床,2004,4(10):737-740. 被引量:5
  • 2SUNIL A A, NADAGOUDA N M, TEJRAJ M A. Recent advances on chitosan-based micro- and nanoparticles in drug delivery[J]. J Control Rel, 2004, 100 (1): 5-28.
  • 3KEVIN A J, MARIE P F, ANA M, et al. Chitosan nanopartieles as delivery systems for doxorubiein[J]. J Control Rel, 2001, 73(2-3): 255-267.
  • 4EMIR B D, EBRU K, CENGIZ B, et al. Magnetic chitosan microspheres: Preparation and Characterlzation[J]. Reactive & Functional Polymers, 2002, 50 (3): 225-232.
  • 5王雷,邓勇华,阿德尔哈米特·欧拉萨.等.一步法合成的磁性聚合物纳米微球及其制备方法.CN1328064A[P],2001.
  • 6曲剑波,褚良银,陈文梅,谢锐,李艳.pH感应型给药系统的研究进展[J].中国医药工业杂志,2004,35(12):757-760. 被引量:3
  • 7ULBRICH K, ETRYCH T, CHYTIL P, et al. Polymeric anticancer drugs with pH-controlled activation[J]. International Journal of Pharmaceuties, 2004, 277(1-2): 63-72.

二级参考文献39

  • 1谭家驹,张春富,冯彦林,曹金全,曹本洪,尹端,汪勇先.靶向治疗用Fe304及其白蛋包被磁性纳米粒子的制备[J].中国医学工程,2003,11(6):30-32. 被引量:5
  • 2[1]Kumar M. Nano and microparticles as controlled drug delivery devices. J Pharm Sci, 2000, 3(2): 234-258.
  • 3[2]Labhaserwar V, Song C, Levy RJ. Nanoparticle and drug delivery system for restenosis. Adv Drug Del Rev, 1997, 24(1): 63.
  • 4[3]Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science, 2004, 303 (5665): 1818-1822.
  • 5[4]Omelyanenko V, Kopeckova P, Geniry C, et al. Targetable HPMA copolymer-adriamycin conjugates: recognition ,internalization,and subcellular fate. J Control Rel, 1998, 53(1-3): 25-37.
  • 6[6]Tadahiko K, Takashi S, Shoji S, et al. Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters. Int J Oncology, 2001, 18(1): 121.
  • 7[10]Gelperina SE, Khalansky AS, Skidan IN, et al. Toxicological studies of doxorubicin bound to polysorbate80-coated poly (butyl-cyanoacrylate)nanoparticles in healthy rats and rats with intracranial glioblastoma. Toxicology Letters, 2002, 126(2): 131-141.
  • 8[11]Kevin AJ, Marie PF, Ana M, et al. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Rel, 2001, 73: 255-267.
  • 9[12]Eliana L, Maria AVI, Riccardo C, et al. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde:involvement of the drug in the cross-linking process. Int J Pharm, 1997, 155(1):75-82.
  • 10[13]Fukashi K, Masayuki Y, Kiyotaka S, et al. Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems J Control Rel, 2002, 78(1-3): 155-163.

共引文献6

同被引文献36

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部